Technical Analysis for ALPMF - Astellas Pharma Inc

Grade Last Price % Change Price Change
grade C 13.76 3.07% 0.4100
ALPMF closed up 3.07 percent on Tuesday, August 20, 2019, on 26 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ALPMF trend table...

Date Alert Name Type % Chg
Cup with Handle Other 0.00%
Narrow Range Bar Range Contraction 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Signal Line Cross Bearish 3.07%
Cup with Handle Other 3.07%
Narrow Range Bar Range Contraction 3.07%
Stochastic Reached Oversold Weakness 3.07%
Down 3 Days in a Row Weakness 3.07%
Down 4 Days in a Row Weakness 3.07%

Older signals for ALPMF ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceutical products worldwide. The company offers XTANDI and Eligard for the treatment of prostate cancer; Betanis/Myrbetriq/BETMIGA for overactive bladder (OAB) treatment; Vesicare forOAB treatment; Harnal/Omnic for functional symptoms associated with benign prostatic hyperplasia; VESOMNI for storage symptoms and voiding symptoms associated with benign prostatic hyperplasia; Prograf and Advagraf/Graceptor/ASTAGRAF XL/Prograf XL, animmunosuppressant; and Funguard/MYCAMINE, a candin-type antifungal agent. It also provides Celecox, an anti-inflammatory agent; Lipitor, a treatment for hypercholesterolemia; Micardis/Micombi/Micamlo, a treatment for hypertension; Symbicort for the treatment for adult bronchial asthma and chronic obstructive pulmonary disease; Bonoteo for the treatment for osteoporosis; Suglat for the treatment of type 2 diabetes; and Repatha for the treatment of hypercholesterolemia. In addition, it offers Lexiscan, a pharmacologic stress agent; Tarceva, a treatment for non-small cell lung cancer; CRESEMBA, a azole antifungal; and Dificlir, a novel treatment for CDI. Additionally, it is developing enzalutamide, gilteritinib, enfortumab vedotin, zolbetuximab, roxadustat, and fezolinetant for oncology indications. The company has a collaboration with Actinium Pharmaceuticals, Inc. to apply Actinium warhead enabling technology platform for generating Actinium radio-conjugates with various Astellas targeting agents. Astellas Pharma Inc. was founded in 1923 and is headquartered in Tokyo, Japan.
Chemistry RTT Diabetes Chemical Compounds Organic Compounds Hypertension Prostate Cancer Osteoporosis Chronic Obstructive Pulmonary Disease Non Small Cell Lung Cancer Mitsubishi Ufj Financial Group Benign Prostatic Hyperplasia Lactams Overactive Bladder Exports Pharmaceutical Products Hypercholesterolemia Hyperplasia Adult Bronchial Asthma Astellas Pharma Enzalutamide Tamsulosin Treatment For Hypertension Treatment For Non Small Cell Lung Cancer Treatment For Osteoporosis Treatment Of Prostate Cancer
Is ALPMF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 17.76
52 Week Low 11.89
Average Volume 5,724
200-Day Moving Average 14.1276
50-Day Moving Average 14.2227
20-Day Moving Average 13.9011
10-Day Moving Average 14.108
Average True Range 0.3427
ADX 12.31
+DI 42.2732
-DI 51.1943
Chandelier Exit (Long, 3 ATRs ) 13.6919
Chandelier Exit (Short, 3 ATRs ) 14.0281
Upper Bollinger Band 14.9762
Lower Bollinger Band 12.826
Percent B (%b) 0.43
BandWidth 15.467841
MACD Line -0.1511
MACD Signal Line -0.1149
MACD Histogram -0.0362
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.7600
Resistance 3 (R3) 13.7600 13.7600 13.7600
Resistance 2 (R2) 13.7600 13.7600 13.7600 13.7600
Resistance 1 (R1) 13.7600 13.7600 13.7600 13.7600 13.7600
Pivot Point 13.7600 13.7600 13.7600 13.7600 13.7600
Support 1 (S1) 13.7600 13.7600 13.7600 13.7600 13.7600
Support 2 (S2) 13.7600 13.7600 13.7600 13.7600
Support 3 (S3) 13.7600 13.7600 13.7600
Support 4 (S4) 13.7600